Category Archives: Stem Cell Advances
Vaccine Innovators Convene to Discuss New Technologies
New technologies to produce vaccines more safely, quickly and economically than traditional approaches are featured at the New Cells, New Vaccines VI: Target to Market international scientific conference, currently underway through March 28 in Wilmington, Delaware, at the Hotel du Pont. Continue reading
Seattle Genetics Announces Pivotal ADCETRIS™ (Brentuximab Vedotin) Hodgkin Lymphoma Study Published in Journal of …
BOTHELL, Wash.–(BUSINESS WIRE)– Seattle Genetics, Inc. (Nasdaq:SGEN – News) today announced that the Journal of Clinical Oncology (JCO) published results of the companys pivotal clinical trial of ADCETRIS (brentuximab vedotin) in Hodgkin lymphoma (HL) patients with relapsed or refractory disease following an autologous stem cell transplant (ASCT). The findings, published today online, demonstrated that treatment with ADCETRIS as a single agent induced durable objective responses in 75 percent of patients and was associated with a manageable safety profile Continue reading
Stem cell therapy possibly helpful in heart failure patients
Public release date: 24-Mar-2012 [ | E-mail | Share ] Contact: Beth Casteel bcasteel@acc.org 240-328-4549 American College of Cardiology CHICAGO — A new study found that using a patient’s own bone marrow cells may help repair damaged areas of the heart caused by heart failure, according to research presented today at the American College of Cardiology’s 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field Continue reading
Pair will receive $250G for outstanding research
A former student and teacher duo at the Massachusetts Institute of Technology will receive $250,000 from the March of Dimes next month for creating advances in treating skin cancers, severe burns and other skin diseases. Howard Green of Brookline, George Higginson professor of cell biology at Harvard Medical School, and his former postdoctoral fellow, Elaine Fuchs, a cell biology professor at Rockefeller University in New York, will be honored at the Fairmont Copley Plaza during a gala hosted by CBS sportscaster Greg Gumbel, an honorary member of the March of Dimes national Board of Trustees. Fuchs began working in Greens lab in 1977 and throughout their careers they have shared their scientific findings, many of which have translated into specific treatments toward pioneering new technologies that explain the molecular underpinnings of skin stem cells and inherited skin disorders Continue reading
BioTimes Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic …
BioTime, Inc. (NYSE Amex: BTX) and BioTimes subsidiary OncoCyte Corporation today provided a progress report on the development of PanC-DxTM, a novel diagnostic device developed at Biotime and OncoCyte to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check-ups. By facilitating early non-invasive cancer detection, PanC-DxTM could lead to more successful therapeutic outcomes while reducing the costs of cancer monitoring and globally increasing the availability of affordable cancer screening. Continue reading
BioTime’s Subsidiary OncoCyte Corporation Provides an Update on the Development of the Novel Pan-Cancer Diagnostic …
ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE Amex: BTX) and BioTimes subsidiary OncoCyte Corporation today provided a progress report on the development of PanC-DxTM, a novel diagnostic device developed at BioTime and OncoCyte to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check-ups. Continue reading
Advances in regenerative medicine spark skin cell banking startup
Weve heard of people freezing their eggs, blood and stem cells for use later on, but a health service startup is now enabling patients to freeze their own skin cells for potential future use in diagnostics, therapeutics and regenerative medicine techniques. Next Healthcare Inc.s goal is to enable personalized healthcare by providing skin and stem cell banking directly to patients through their medical professional. Technologies that utilize human skin cells and stem cells are rapidly evolving, the company says on its website. Continue reading
Third Aesthetic Plastic Surgery / Anti Aging Medicine: The Next Generation Symposium Brings Industry Leading Courses …
New York, March 21, 2012 /PRNewswire/ –The third Aesthetic Plastic Surgery / Anti Aging Medicine: The Next Generation Symposium will be held on July 20-22, 2012 at the Conrad New York, a new luxury complex overlooking the Hudson River in lower Manhattan. This interactive, multidisciplinary conference brings together world-class faculty from around the globe who will share ground-breaking research and practical advancements in aesthetic surgery, cosmetic medicine and anti-aging therapy Continue reading
Global Laboratory Chemical Reagents Market to Reach US$18 Billion by 2017, According to New Report by Global Industry …
GIA announces the release of a comprehensive global report on Laboratory Chemical Reagents market. The global market for Laboratory Chemical Reagents is projected to reach US$18 billion by the year 2017, driven by technological advancements that are enhancing scientific communitys ability to identify and produce important human therapeutic agents. Continue reading
To fix a heart, doctors train girl's body to grow new part
Four-year-old Angela Irizarry was born with a single pumping chamber in her heart, a potentially lethal defect. To fix the problem, Angela is growing a new blood vessel in her body in an experimental treatment that could advance the burgeoning field of regenerative medicine Continue reading